228. Bronchiolitis obliterans Clinical trials / Disease details
Clinical trials : 96 / Drugs : 125 - (DrugBank : 34) / Drug target genes : 33 - Drug target pathways : 155
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02863835 (ClinicalTrials.gov) | April 2016 | 4/5/2016 | Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients | Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients | Transplantation, Heart-Lung;Chronic Lung Allograft Dysfunction;Bronchiolitis Obliterans Syndrome | Other: EIT;Other: Salbutamol nebulisation and with CPAP | Guy's and St Thomas' NHS Foundation Trust | ADIR Association | Completed | 18 Years | 70 Years | All | 50 | N/A | United Kingdom |